PW Medtech Group Limited (incorporated in the Cayman Islands) disclosed its Monthly Return on Movements in Securities for the period ended 31 August 2026. The filing shows no changes to either authorised or issued share capital during the month, while confirming that the company continues to meet the Hong Kong Stock Exchange’s minimum 25% public-float requirement.

Authorised / Registered Capital • Authorised share capital remained unchanged at 5.00 billion ordinary shares with a par value of USD 0.0001 each, equivalent to USD 0.50 million in aggregate.

Issued Shares and Treasury Position • Issued shares (excluding treasury shares) stood at 1.43 billion; no new shares were issued and no treasury shares were created or cancelled in August. • Although the monthly balance was flat, a repurchase of 2.42 million shares executed on 26 June 2026 is pending formal cancellation and is therefore reflected as a negative adjustment under “Other Movements” in the return.

Capital Management Instruments • The company reported no outstanding share options, warrants, convertible securities or other equity-linked instruments during the month.

Regulatory Compliance • Director Yue’e Zhang confirmed that all applicable Hong Kong listing rules and legal requirements were observed, and that the company’s public float comfortably exceeds the 25% threshold stipulated by Main Board Rule 13.32B.